October 25, 2013

With is proposed acquisition of German wholesaler Celesio, McKesson creates a global distribution enterprise on the scale of Walgreens, Alliance Boots and AmerisourceBergen before them. In addition to wholesaling, Celesio operates about 2,200 pharmacies across six countries and is the No. 2 operator in the United Kingdom.

Retail pharmacy and drug sourcing both are more and more becoming a global business. Just last week, the head of the second-biggest drug chain in Brazil announced he would be open to a buyout. So expect more of these headlines in the months to come.

October 24, 2013

McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.

October 1, 2013

Walgreens posted a sales gain of 0.8% for the fiscal year ended Aug. 31, reaching a record $72.2 billion and filling a record 821 million prescriptions.

September 20, 2013

Alliance Boots announced that it is establishing a specialized investment fund, B&B Capital Partners, which will be focused on small- and medium-sized consumer brand businesses within the health, wellness, beauty and personal care sectors.

August 19, 2013

Walgreens last week made several executive moves to boost its Daily Living business organization, chief of which was the announcement that Alex Gourlay will make the transition from chief executive of Alliance Boots' health and beauty division to EVP, president of customer experience and daily living for Walgreens. http://www.drugstorenews.com/article/walgreens-announces-enhanced-daily-...

Gorley will fill in the vision and leadership hole Joe Magnacca left when he departed Walgreens to take on challenge of reinventing Radio Shack. The move showcases the kind of extended depth chart that is now enjoyed across Walgreens and Alliance Boots and takes Walgreens' strategy of tapping the best executives to fill strategic positions to a whole new global level.

August 14, 2013

Walgreens announced an enhanced Daily Living business organization with the promotion and leadership expansion of key marketing and merchandising executives.

July 23, 2013

Skin care brand Indeed Laboratories is bringing its nanoblur and snoxin skin care products to the U.S. market, through distributor Boots USA, with exclusive availability at Walgreens and Duane Reade stores.

June 21, 2013

No7 Men skin care products, part of the U.K.’s skin care brand No7 created by Boots, is now available chainwide at Walgreens and Duane Reade stores.

May 17, 2013

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse.

A couple days later, Alliance Boots along with Walgreens and AmerisourceBergen announced the necessary regulatory clearances on that strategic partnership, cementing the three companies in place as the largest generic pharmaceutical acquisition company in the world. That deal will further enable the company's to realize greater profit margins.

May 17, 2013

The deal that paired Walgreens and Alliance Boots with wholesaler AmerisourceBergen has received the required regulatory clearances, the companies announced Friday.

May 15, 2013

Alliance Boots on Wednesday reported a double-digit profit gain for its year ended March 31.

May 10, 2013

Alliance Boots on Friday announced that it has distributed its equity interest in Galenica, its Swiss associate, to the group’s ultimate parent company, AB Acquisitions Holdings, in accordance with the terms of the agreement with Walgreens reached last year.

April 26, 2013

Cardinal Health announced the renewal of its pharmaceutical distribution agreement with CVS Caremark to supply pharmaceuticals to the company’s retail pharmacies and distribution centers, as McKesson, which generally serves the PBM side of the business, also announced the renewal of its current distribution agreement with the pharmacy retailer.

The renewal of the agreements was not only critical for both companies but, as Adam Fein, president of Pembroke Consulting and CEO of Drug Channels Institute, wrote in his blog “CVS Caremark Renews with Cardinal and McKesson,” it also “demonstrates wholesalers' value in the brand-name pharmacy supply chain.”

April 26, 2013

AmerisourceBergen's base of 3,452 independently owned Good Neighbor Pharmacies will be another benefactor out of the wholesaler's blockbuster agreement with Walgreens and Alliance Boots, AmerisourceBergen CEO, president, director and chairman Steven Collis told analysts during a conference call Thursday.

April 22, 2013

To the skepticism of many, Walgreens last year made a big global splash with its two-step merger deal with Alliance Boots across the pond. But with the announcement that the co-joined Walgreens/Alliance Boots had signed a 10-year distribution deal with wholesaler AmerisourceBergen, that included an equity stake to boot, well, it seemed that many analysts on Wall Street finally got it.

April 21, 2013

It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.

March 27, 2013

Alliance Boots on Wednesday announced its contract manufacturing business BCM will invest heavier into core competency categories, such as beauty and skin care, as it discontinues third-party manufacturer development in unnamed "unprofitable" categories.

March 22, 2013

Walgreens and Alliance Boots entered into a 10-year contract with wholesaler AmerisourceBergen on sourcing pharmaceuticals last week. But that's not all. Besides the long-term contract, Walgreens and Alliance Boots will have the option on a potential 23% equity stake in ABC in three years.

The deal takes pharmaceutical buying leverage to the stratosphere and changes the face of more than one health service industry. As Adam Fein, president of Pembroke Consulting, noted in a live television interview on Fox Business' "Money With Melissa Francis": "Three of the largest companies in the pharmaceutical industry have come together and built the single largest buyer of prescription drugs in the world," he said.

March 19, 2013

Even as Walgreens expands its operation globally through strategic partnerships with both Alliance Boots and now AmerisourceBergen, the pharmacy operator continues to create some retail pop in the U.S. market.

March 19, 2013

Walgreens will no longer source branded prescription medicines directly from suppliers beginning in September, the Chicago-based retailer announced as part of a significant partnership between Walgreens, Alliance Boots and AmerisourceBergen that includes Walgreens and Alliance Boots potentially taking a 7% stake in the Pennsylvania wholesaler.

February 13, 2013

Walgreens and Alliance Boots will generate $130 billion or more in combined sales, Greg Wasson, Walgreens president and CEO told analysts Wednesday.

January 11, 2013

Walgreens chief Greg Wasson had a new vision to share with the pharmacy operator's faithful shareholders for 2013. It was a vision that firmly placed the Express Scripts dispute in the rear-view mirror and refocused on the road ahead that includes expanding the role of pharmacy and even what it means to be a U.S. pharmacy operator with its acquisition of Alliance Boots.

Two major announcements were made in the wake of the shareholders meeting, both of which were identified by DSN as two of the top six big trends to watch through 2013. Walgreens reiterated its commitment to fostering an omnichannel experience for its shoppers and, a day after the shareholders meeting, Walgreens became the only retail pharmacy operator to partner on three Accountable Care Organizations.

January 9, 2013

"2012 was definitely an important year for Walgreens," Greg Wasson, Walgreens president and CEO, told shareholders here Wednesday afternoon at the chain's annual shareholder meeting. "We did make some tough choices to protect and solidify … our position for the long term," he said. "[But] our vision is crystal clear to become the first choice for health and daily living in America."

January 4, 2013

Following the "People’s Choice Awards," Walgreens is celebrating its involvement in the awards by hosting “Night at the W” events at its stores nationwide on Jan. 10.

The “Night at the W,” which leverages the expertise of its beauty advisers, is yet another example of how the pharmacy retailer is elevating the beauty experience at mass. And the event is an ideal way to promote its beauty advisers.